Susceptibility of germ-free pigs to challenge with protease mutants of Salmonella enterica serovar Typhimurium
Language English Country Netherlands Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
17678715
DOI
10.1016/j.imbio.2007.05.001
PII: S0171-2985(07)00067-8
Knihovny.cz E-resources
- MeSH
- Cell Line MeSH
- Cytokines immunology metabolism MeSH
- Germ-Free Life MeSH
- Macrophages immunology microbiology MeSH
- Mutation MeSH
- Disease Susceptibility MeSH
- Swine MeSH
- Peptide Hydrolases genetics metabolism MeSH
- Salmonella typhimurium enzymology genetics immunology pathogenicity MeSH
- Salmonella Infections, Animal immunology metabolism microbiology MeSH
- Salmonella Vaccines immunology MeSH
- Virulence MeSH
- Animals MeSH
- Check Tag
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Cytokines MeSH
- Peptide Hydrolases MeSH
- Salmonella Vaccines MeSH
Salmonella protease mutants, clpP and especially htrA, are candidate live oral vaccines in humans. A functional and mature immune system is, however, required to cope with them in mice. Here, we test the cytokine response of highly susceptible germ-free pigs to infection with Salmonella Typhimurium clpP and htrA mutants. Cytokine levels (IL-4, IL-10, IL-18 and IFN-gamma) were measured by ELISA in plasma and washes from the terminal small bowel 24h after oral challenge. Unlike the infection with the wild type strain, no IFN-gamma response and low IL-18 intestinal levels were found in pigs infected with the protease mutants. Despite this and regardless of partially reduced ability of htrA and clpP mutants to invade and multiply in a 3D4 porcine macrophage-like cell line, both the mutants were as virulent as was the wild type LT2 strain and caused fatal septicaemia in germ-free pigs. IFN-gamma and IL-18 response therefore did not correlate with the virulence of Salmonella Typhimurium. Our results indicate that htrA and clpP attenuations should be used with caution in populations in which an increased number of immunocompromised individuals can be expected.
References provided by Crossref.org